SCHEMBL30728153

SCHEMBL30728153

O=C(O)c1cncc2[nH]ncc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDO2 P48775 1/20 0.36
CCNA2 P20248 1/20 0.35
CDK2 P24941 1/20 0.35
CCNA1 P78396 1/20 0.35
ABL1 P00519 1/20 0.34
HCAR2 Q8TDS4 2/20 0.33
METAP2 P50579 1/20 0.33
NOS1 P29475 3/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
KDM6B O15054 1/20 0.32
KDM4A O75164 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
THRB P10828 1/20 0.32
KMT2A Q03164 1/20 0.32
KDM4D Q6B0I6 1/20 0.32
KDM4C Q9H3R0 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31179362 0.79 TSHR (0.51) TDO2KDM4EMEN1ALDH1A1MAPT
SCHEMBL260364 0.76 NOS1 (0.52) METAP2NOS1ALDH1A1AXL
SCHEMBL30285533 0.76 NOS1 (0.52) METAP2NOS1ALDH1A1AXL
Hydrochloric Acid SCHEMBL1056437 0.74 NOS1 (0.50) METAP2NOS1ALDH1A1AXL
SCHEMBL2595232 0.73 METAP2 (0.51) METAP2
SCHEMBL459215 0.73 TDO2 (0.54) TDO2METAP2NOS1
SCHEMBL16806087 0.73 IDO1 (0.53) TDO2METAP2KDM4E
SCHEMBL5302911 0.72 PIK3C3 (0.41) KDM4EMEN1KDM6BKDM4AALDH1A1
SCHEMBL30927021 0.72 PIK3C3 (0.41) KDM4EMEN1KDM6BKDM4AALDH1A1
SCHEMBL15378479 0.71 NOS1 (0.36) TDO2CCNA2CDK2CCNA1ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4558501-A1 CBL-B INHIBITORS AND METHODS OF USE THEREOF Arcus Biosciences, Inc. (US) 2025-05-28 EP disclosed
WO-2025054488-A1 TRICYCLIC DERIVATIVES AND RELATED USES MOMA THERAPEUTICS, INC. (US) 2025-03-13 WO disclosed
WO-2024020034-A1 CBL-B INHIBITORS AND METHODS OF USE THEREOF ARCUS BIOSCIENCES, INC. (US) 2024-01-25 WO disclosed